Kraig Biocraft Laboratories Inc (KBLB)

[Jakito]

You’ve answered your own question in your ramble.

“Some institutions may still not want to invest in an otc company”

And it’s really about them being constrained by their own investment rules not as basic as saying they don’t want to.

This, and the ongoing ability to raise finance from a much wider range of institutions through further share placings/offerings as and when needed for further expansion, partnerships, acquisitions JV’s...

And maybe lastly just the slight improvement in prestige that comes with the uplist, as you have been keen to point out how terrible the OTC is over the years.